MedPath

ZAXINE

ZAXINE

Approved
DIN Number

02410702

Drug Class

Human

Market Date

Nov 7, 2013

Company
HC

SALIX PHARMACEUTICALS INC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02410702
AIG Number0154590001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A07AA11 RIFAXIMIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:12.28.30
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIFAXIMINActive
Strength: 550 MG
Monograph: RIFAXIMIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.